8-K: Novanta Revises 2025 EPS Guidance Post-Equity Issuance

Novanta Inc. has revised its fourth quarter and full year 2025 non-GAAP adjusted diluted earnings per share guidance downwards following a recent equity issuance.

Summary

• Revised non-GAAP Adjusted Diluted EPS guidance for Q4 2025 is $0.84 to $0.91, down from the prior guidance of $0.87 to $0.93.
• Revised non-GAAP Adjusted Diluted EPS guidance for full year 2025 is $3.21 to $3.28, down from the prior guidance of $3.24 to $3.30.
• The revision reflects the share impact from a recent equity issuance.
• The weighted average diluted shares outstanding impact for Q4 2025 is expected to be between 2.5 million and 2.6 million shares.
• The weighted average diluted shares outstanding impact for full year 2025 is expected to be between 0.6 million and 0.7 million shares.
• The estimated full year 2026 diluted shares outstanding impact is between 4.7 million and 5.9 million shares.
• GAAP revenue guidance for Q4 2025 remains unchanged at $253 million to $257 million.
• GAAP revenue guidance for full year 2025 remains unchanged at $975 million to $979 million.
• Adjusted EBITDA guidance for Q4 2025 remains unchanged at $62 million to $65 million.
• Adjusted EBITDA guidance for full year 2025 remains unchanged at $222 million to $225 million.

Sentiment

Score: 4

Explanation: The downward revision of EPS guidance due to share dilution is a negative, even if operational guidance remains stable. While the capital raise itself might be for strategic growth, the immediate impact on per-share earnings is unfavorable.

Positives

• GAAP revenue guidance for Q4 2025 ($253 million to $257 million) and full year 2025 ($975 million to $979 million) remains unchanged, indicating stable top-line expectations.
• Adjusted EBITDA guidance for Q4 2025 ($62 million to $65 million) and full year 2025 ($222 million to $225 million) remains unchanged, suggesting operational profitability is in line with previous expectations.

Negatives

• Fourth quarter 2025 non-GAAP Adjusted Diluted EPS guidance was revised downwards from $0.87-$0.93 to $0.84-$0.91.
• Full year 2025 non-GAAP Adjusted Diluted EPS guidance was revised downwards from $3.24-$3.30 to $3.21-$3.28.
• The downward revision in EPS guidance is attributed to the dilutive effect of a recent equity issuance, increasing the number of shares outstanding.

Risks

• Economic and political conditions and their effects on customer businesses, capital expenditures, and level of business activities.
• Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the statements.
• Other important risk factors are found in Part I, Item 1A of the Annual Report on Form 10-K for the fiscal year ended December 31, 2024, as updated by subsequent filings with the Securities and Exchange Commission.

Future Outlook

Novanta Inc. has revised its non-GAAP Adjusted Diluted EPS guidance for the fourth quarter and full year 2025 downwards, reflecting the dilutive impact of a recent equity issuance. However, GAAP revenue and Adjusted EBITDA guidance for these periods remain unchanged. The full year 2026 diluted shares outstanding impact is estimated between 4.7 million and 5.9 million shares.

Industry Context

This filing is specific to Novanta's internal financial adjustments following an equity issuance and does not provide information to analyze broader industry trends or competitor performance. The unchanged revenue and EBITDA guidance suggest operational performance is in line with previous expectations, while the EPS revision is a capital structure effect.

Stakeholder Impact

• Shareholders: Existing shareholders will experience dilution, leading to lower earnings per share. New shareholders from the equity issuance will own a portion of the company.
• Investors: The revised, lower EPS guidance may influence investment decisions and stock valuation.

Key Dates

Recommendation

While the downward revision in EPS guidance is a negative, it stems from a capital structure event (equity issuance) rather than a deterioration in core operational performance, as revenue and EBITDA guidance remain unchanged. This suggests the underlying business is performing as expected. Investors should hold to observe how the capital raised from the equity issuance is deployed and its impact on future growth and profitability, which could eventually offset the dilution. The immediate impact is dilutive, but the long-term strategic benefits of the capital raise are yet to be seen.

Keywords

Novanta, NOVT, SEC filing, 8-K, financial guidance, EPS, earnings per share, adjusted diluted EPS, equity issuance, shares outstanding, revenue, EBITDA, Q4 2025, full year 2025, 2026 guidance, capital raise, investor relations